x
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934 for the Quarter Ended September 30,
2006
|
o
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
Delaware
|
04-2209186
|
(State
of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
|
|
81
Wyman Street, P.O. Box 9046
|
|
Waltham,
Massachusetts
|
02454-9046
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Class
|
|
Outstanding
at October 27, 2006
|
||
Common
Stock, $1.00 par value
|
|
158,020,239
|
September
30,
|
December
31,
|
||||||
(In
thousands)
|
2006
|
2005
|
|||||
Current
Assets:
|
|||||||
Cash and cash equivalents
|
$
|
157,964
|
$
|
214,326
|
|||
Short-term available-for-sale investments, at quoted market value
(amortized cost of $14,431
and $80,661)
|
14,679
|
80,661
|
|||||
Accounts
receivable, less allowances of $23,001 and $21,841
|
539,839
|
560,172
|
|||||
Inventories:
|
|||||||
Raw
materials and supplies
|
147,415
|
133,774
|
|||||
Work
in process
|
60,804
|
50,043
|
|||||
Finished
goods
|
199,253
|
175,575
|
|||||
Deferred
tax assets
|
80,121
|
79,586
|
|||||
Other
current assets
|
78,501
|
59,763
|
|||||
1,278,576
|
1,353,900
|
||||||
Property,
Plant and Equipment, at Cost
|
544,180
|
515,385
|
|||||
Less:
Accumulated depreciation and amortization
|
263,664
|
234,731
|
|||||
280,516
|
280,654
|
||||||
Acquisition-related
Intangible Assets
|
405,470
|
450,740
|
|||||
Other
Assets
|
219,691
|
200,080
|
|||||
Goodwill
|
2,013,985
|
1,966,195
|
|||||
$
|
4,198,238
|
$
|
4,251,569
|
September
30,
|
December
31,
|
||||||
(In
thousands except share amounts)
|
2006
|
2005
|
|||||
Current
Liabilities:
|
|||||||
Short-term obligations and current maturities of long-term
obligations
|
$
|
68,658
|
$
|
130,137
|
|||
Accounts
payable
|
154,546
|
153,475
|
|||||
Accrued
payroll and employee benefits
|
108,834
|
114,707
|
|||||
Accrued
income taxes
|
28,186
|
55,147
|
|||||
Deferred
revenue
|
96,066
|
85,592
|
|||||
Customer
deposits
|
44,160
|
38,229
|
|||||
Accrued
warranty costs (Note 10)
|
36,213
|
33,453
|
|||||
Other
accrued expenses (Notes 2 and 11)
|
186,160
|
180,922
|
|||||
722,823
|
791,662
|
||||||
Deferred
Income Taxes
|
42,582
|
65,015
|
|||||
Other
Long-term Liabilities
|
147,905
|
132,950
|
|||||
Long-term
Obligations:
|
|||||||
Senior
notes (Note 9)
|
382,175
|
380,542
|
|||||
Subordinated
convertible obligations
|
77,234
|
77,234
|
|||||
Other
|
10,477
|
10,854
|
|||||
469,886
|
468,630
|
||||||
Shareholders’
Equity:
|
|||||||
Preferred stock, $100 par value, 50,000 shares authorized; none
issued
|
|||||||
Common stock, $1 par value, 350,000,000 shares authorized; 163,360,801
and
181,817,452 shares issued
|
163,361
|
181,817
|
|||||
Capital
in excess of par value (Note 6)
|
971,873
|
1,421,382
|
|||||
Retained
earnings
|
1,748,094
|
1,604,475
|
|||||
Treasury
stock at cost, 5,600,554 and 19,335,163 shares (Note 6)
|
(145,821
|
)
|
(437,707
|
)
|
|||
Deferred
compensation
|
—
|
(3,834
|
)
|
||||
Accumulated
other comprehensive items (Note 6)
|
77,535
|
27,179
|
|||||
2,815,042
|
2,793,312
|
||||||
$
|
4,198,238
|
$
|
4,251,569
|
Three
Months Ended
|
|||||||
September
30,
|
October
1,
|
||||||
(In
thousands except per share amounts)
|
2006
|
2005
|
|||||
Revenues
|
$
|
724,962
|
$
|
679,411
|
|||
Costs
and Operating Expenses:
|
|||||||
Cost
of revenues
|
388,077
|
373,712
|
|||||
Selling,
general and administrative expenses
|
217,938
|
194,323
|
|||||
Research
and development expenses
|
38,658
|
38,784
|
|||||
Restructuring
and other costs, net (Note 11)
|
5,178
|
10,482
|
|||||
649,851
|
617,301
|
||||||
Operating
Income
|
75,111
|
62,110
|
|||||
Other
Expense, Net (Note 4)
|
(5,743
|
)
|
(2,751
|
)
|
|||
Income from Continuing Operations Before Provision for Income
Taxes
|
69,368
|
59,359
|
|||||
Provision
for Income Taxes
|
(20,535
|
)
|
(18,762
|
)
|
|||
Income
from Continuing Operations
|
48,833
|
40,597
|
|||||
Gain on Disposal of Discontinued Operations (net of income tax
provision
of $11,456; Note 13)
|
—
|
17,137
|
|||||
Net
Income
|
$
|
48,833
|
$
|
57,734
|
|||
Earnings per Share from Continuing Operations (Note 5):
|
|||||||
Basic
|
$
|
.31
|
$
|
.25
|
|||
Diluted
|
$
|
.30
|
$
|
.25
|
|||
Earnings
per Share (Note 5):
|
|||||||
Basic
|
$
|
.31
|
$
|
.36
|
|||
Diluted
|
$
|
.30
|
$
|
.35
|
|||
Weighted
Average Shares (Note 5):
|
|||||||
Basic
|
157,705
|
161,794
|
|||||
Diluted
|
162,161
|
165,635
|
Nine
Months Ended
|
|||||||
|
September
30,
|
October
1,
|
|||||
(In
thousands except per share amounts)
|
2006
|
2005
|
|||||
Revenues
|
$
|
2,122,717
|
$
|
1,892,240
|
|||
Costs
and Operating Expenses:
|
|||||||
Cost
of revenues
|
1,148,716
|
1,039,852
|
|||||
Selling,
general and administrative expenses
|
627,305
|
550,417
|
|||||
Research
and development expenses
|
118,015
|
114,544
|
|||||
Restructuring
and other costs, net (Note 11)
|
13,552
|
12,427
|
|||||
1,907,588
|
1,717,240
|
||||||
Operating
Income
|
215,129
|
175,000
|
|||||
Other
Income (Expense), Net (Note 4)
|
(12,905
|
)
|
26,057
|
||||
Income from Continuing Operations Before Provision for Income
Taxes
|
202,224
|
201,057
|
|||||
Provision
for Income Taxes
|
(60,829
|
)
|
(58,117
|
)
|
|||
Income
from Continuing Operations
|
141,395
|
142,940
|
|||||
Gain on Disposal of Discontinued Operations, Net (net of income
tax
provision of $1,303 and $15,728; Note 13)
|
2,224
|
23,873
|
|||||
Net
Income
|
$
|
143,619
|
$
|
166,813
|
|||
Earnings per Share from Continuing Operations (Note 5):
|
|||||||
Basic
|
$
|
.88
|
$
|
.89
|
|||
Diluted
|
$
|
.86
|
$
|
.87
|
|||
Earnings
per Share (Note 5):
|
|||||||
Basic
|
$
|
.89
|
$
|
1.03
|
|||
Diluted
|
$
|
.88
|
$
|
1.02
|
|||
Weighted
Average Shares (Note 5):
|
|||||||
Basic
|
160,680
|
161,335
|
|||||
Diluted
|
164,889
|
165,008
|
Nine
Months Ended
|
|||||||
|
September
30,
|
October
1,
|
|||||
(In
thousands)
|
2006
|
2005
|
|||||
Operating
Activities:
|
|||||||
Net income
|
$
|
143,619
|
$
|
166,813
|
|||
Gain on disposal of discontinued operations, net
|
(2,224
|
)
|
(23,873
|
)
|
|||
Income from continuing operations
|
141,395
|
142,940
|
|||||
Adjustments to reconcile income from continuing operations to
net cash
provided by operating
activities:
|
|||||||
Depreciation
and amortization
|
116,262
|
85,344
|
|||||
Noncash
restructuring and other costs, net
|
126
|
1,723
|
|||||
Provision
for losses on accounts receivable
|
1,440
|
1,451
|
|||||
Change
in deferred income taxes
|
(28,543
|
)
|
(3,197
|
)
|
|||
Gain
on sale of product lines, net
|
(556
|
)
|
(119
|
)
|
|||
Gain
on investments, net
|
(902
|
)
|
(34,761
|
)
|
|||
Noncash
equity compensation
|
20,134
|
2,067
|
|||||
Other
noncash expenses, net
|
29
|
14,780
|
|||||
Changes in current accounts, excluding the effects of acquisitions
and
dispositions:
|
|||||||
Accounts receivable
|
42,700
|
(8,780
|
)
|
||||
Inventories
|
(31,027
|
)
|
(15,495
|
)
|
|||
Other current assets
|
(14,382
|
)
|
(15,075
|
)
|
|||
Accounts payable
|
(8,340
|
)
|
(8,347
|
)
|
|||
Other current liabilities
|
(37,934
|
)
|
(16,020
|
)
|
|||
Net
cash provided by continuing operations
|
200,402
|
146,511
|
|||||
Net
cash used in discontinued operations
|
(161
|
)
|
(1,647
|
)
|
|||
Net
cash provided by operating activities
|
200,241
|
144,864
|
|||||
Investing
Activities:
|
|||||||
Acquisitions,
net of cash acquired
|
(59,208
|
)
|
(939,436
|
)
|
|||
Proceeds
from sale of available-for-sale investments
|
151,012
|
352,326
|
|||||
Purchases
of available-for-sale investments
|
(83,979
|
)
|
(148,500
|
)
|
|||
Purchases
of property, plant and equipment
|
(31,814
|
)
|
(27,125
|
)
|
|||
Proceeds
from sale of property, plant and equipment
|
4,611
|
10,026
|
|||||
Proceeds
from sale of product lines
|
8,875
|
5,661
|
|||||
Collection
of notes receivable
|
2,805
|
—
|
|||||
Proceeds
from sale of other investments
|
1,942
|
2,113
|
|||||
Increase
in other assets
|
(1,983
|
)
|
(1,977
|
)
|
|||
Other
|
(531
|
)
|
(97
|
)
|
|||
Net
cash used in continuing operations
|
(8,270
|
)
|
(747,009
|
)
|
|||
Net
cash provided by discontinued operations
|
5,333
|
65,042
|
|||||
Net
cash used in investing activities
|
$
|
(2,937
|
)
|
$
|
(681,967
|
)
|
Nine
Months Ended
|
|||||||
|
September
30,
|
October
1,
|
|||||
(In
thousands)
|
2006
|
2005
|
|||||
Financing
Activities:
|
|||||||
Purchases of company common stock
|
$
|
(228,001
|
)
|
$
|
—
|
||
Net
proceeds from issuance of long-term debt
|
—
|
246,965
|
|||||
Increase
(decrease) in
short-term notes payable
|
(66,916
|
)
|
155,741
|
||||
Net proceeds from issuance of company common stock
|
26,382
|
21,739
|
|||||
Borrowings under short-term bridge financing agreement
|
—
|
570,000
|
|||||
Repayment of bridge financing agreement
|
—
|
(570,000
|
)
|
||||
Tax benefits from exercised stock options (Note 7)
|
6,662
|
—
|
|||||
Other
|
(175
|
)
|
(2,320
|
)
|
|||
Net
cash provided by (used in) financing activities
|
(262,048
|
)
|
422,125
|
||||
Exchange
Rate Effect on Cash of Continuing Operations
|
8,382
|
(18,449
|
)
|
||||
Decrease
in Cash and Cash Equivalents
|
(56,362
|
)
|
(133,427
|
)
|
|||
Cash
and Cash Equivalents at Beginning of Period
|
214,326
|
326,886
|
|||||
Cash
and Cash Equivalents at End of Period
|
$
|
157,964
|
$
|
193,459
|
|||
Noncash
Investing Activities:
|
|||||||
Fair
value of assets of acquired businesses
|
$
|
91,581
|
$
|
1,103,872
|
|||
Cash
paid for acquired businesses
|
(61,015
|
)
|
(946,935
|
)
|
|||
Liabilities
of acquired businesses
|
$
|
30,566
|
$
|
156,937
|
1.
|
General
|
2.
|
Merger
and Acquisitions
|
2.
|
Merger
and Acquisitions (continued)
|
(In
thousands)
|
GVI
|
EGS
|
Other
|
Total
|
|||||||||
Purchase
Price:
|
|||||||||||||
Cash
paid (a)
|
$
|
21,916
|
$
|
27,816
|
$
|
11,283
|
$
|
61,015
|
|||||
Cash
acquired
|
(377
|
)
|
(1,416
|
)
|
(14
|
)
|
(1,807
|
)
|
|||||
$
|
21,539
|
$
|
26,400
|
$
|
11,269
|
$
|
59,208
|
||||||
Allocation:
|
|||||||||||||
Current
assets
|
$
|
10,753
|
$
|
7,385
|
$
|
1,525
|
$
|
19,663
|
|||||
Property,
plant and equipment
|
337
|
806
|
61
|
1,204
|
|||||||||
Acquired
intangible assets
|
7,780
|
14,635
|
6,420
|
28,835
|
|||||||||
Goodwill
|
17,996
|
14,113
|
5,552
|
37,661
|
|||||||||
Other
assets
|
—
|
786
|
1,625
|
2,411
|
|||||||||
Liabilities
assumed
|
(15,327
|
)
|
(11,325
|
)
|
(3,914
|
)
|
(30,566
|
)
|
|||||
$
|
21,539
|
$
|
26,400
|
$
|
11,269
|
$
|
59,208
|
(a) |
Includes
transaction costs.
|
2.
|
Merger
and Acquisitions (continued)
|
(In
thousands)
|
GVI
|
EGS
|
Other
|
Total
|
|||||||||
Customer
Relationships
|
$
|
4,215
|
$
|
9,217
|
$
|
3,045
|
$
|
16,477
|
|||||
Product
Technology
|
3,565
|
5,418
|
3,375
|
12,358
|
|||||||||
$
|
7,780
|
$
|
14,635
|
$
|
6,420
|
$
|
28,835
|
|
Nine
Months Ended
|
|||
(In
thousands except per share amounts)
|
October
1, 2005
|
Revenues
|
$
|
2,020,559
|
||
Net
Income
|
$
|
155,197
|
||
Earnings per Share from Continuing Operations:
|
||||
Basic
|
$
|
.81
|
||
Diluted
|
$
|
.80
|
||
Earnings
Per Share:
|
||||
Basic
|
$
|
.96
|
||
Diluted
|
$
|
.95
|
2.
|
Merger
and Acquisitions (continued)
|
(In
thousands)
|
Severance
|
|||
Reserves established
|
$
|
536
|
||
Payments
|
(274
|
)
|
||
Currency translation
|
10
|
|||
Balance
at September 30, 2006
|
$
|
272
|
(In
thousands)
|
Severance
|
Abandonment
of
Excess
Facilities
|
Other
|
Total
|
|||||||||
Balance
at December 31, 2005
|
$
|
2,494
|
$
|
345
|
$
|
73
|
$
|
2,912
|
|||||
Reserves
established
|
3,213
|
531
|
629
|
4,373
|
|||||||||
Payments
|
(1,969
|
)
|
(108
|
)
|
—
|
(2,077
|
)
|
||||||
Decrease
recorded as a reduction in goodwill
|
(427
|
)
|
—
|
(537
|
)
|
(964
|
)
|
||||||
Currency
translation
|
376
|
36
|
8
|
420
|
|||||||||
Balance
at September
30, 2006
|
$
|
3,687
|
$
|
804
|
$
|
173
|
$
|
4,664
|
(In
thousands)
|
Severance
|
Abandonment
of
Excess
Facilities
|
Total
|
|||||||
Balance
at December 31,
2005
|
$
|
139
|
$
|
3,212
|
$
|
3,351
|
||||
Payments
|
—
|
(1,163
|
)
|
(1,163
|
)
|
|||||
Divestiture
|
—
|
(199
|
)
|
(199
|
)
|
|||||
Decrease
recorded as a reduction in goodwill
|
(15
|
)
|
(211
|
)
|
(226
|
)
|
||||
Currency
translation
|
10
|
277
|
287
|
|||||||
Balance
at September
30, 2006
|
$
|
134
|
$
|
1,916
|
$
|
2,050
|
3.
|
Business
Segment Information
|
|
Life
and
Laboratory
Sciences
|
Measurement
and Control
|
Eliminations
and
Other
|
Corporate
|
Total
|
|||||||||||||
(In
thousands)
|
||||||||||||||||||
Three
Months Ended September 30, 2006
|
||||||||||||||||||
Revenues
|
$
|
543,470
|
$
|
181,492
|
$
|
—
|
$
|
—
|
$
|
724,962
|
||||||||
Adjusted
operating income (a)
|
$
|
99,689
|
$
|
25,764
|
$
|
(3,699
|
)
|
$
|
(13,076
|
)
|
$
|
108,678
|
(b)
|
|
||||
Cost
of revenues charges
|
(1,458
|
)
|
(526
|
)
|
—
|
—
|
(1,984
|
)
|
||||||||||
Restructuring
and other items
|
(969
|
)
|
(2,612
|
)
|
—
|
(1,597
|
)
|
(5,178
|
)
|
|||||||||
Stock
option compensation expense
|
(2,863
|
)
|
(836
|
)
|
3,699
|
—
|
—
|
|||||||||||
Amortization
|
(24,491
|
)
|
(1,918
|
)
|
—
|
4
|
(26,405
|
)
|
||||||||||
Operating
income
|
69,908
|
19,872
|
—
|
(14,669
|
)
|
75,111
|
(b)
|
|
||||||||||
Other
expense, net
|
(5,743
|
)
|
||||||||||||||||
Income from continuing operations before provision for
income taxes
|
$
|
69,368
|
||||||||||||||||
Depreciation
|
$
|
9,450
|
$
|
2,300
|
$
|
—
|
$
|
1,670
|
$
|
13,420
|
||||||||
Three
Months Ended October 1, 2005
|
||||||||||||||||||
Revenues
|
$
|
516,047
|
$
|
163,364
|
$
|
—
|
$
|
—
|
$
|
679,411
|
||||||||
Adjusted
operating income (a)
|
$
|
88,263
|
$
|
20,084
|
$
|
—
|
$
|
(8,430
|
)
|
$
|
99,917
|
(c)
|
|
|||||
Cost
of revenues charges
|
(1,142
|
)
|
(614
|
)
|
—
|
—
|
(1,756
|
)
|
||||||||||
Restructuring
and other items
|
(6,823
|
)
|
(3,445
|
)
|
—
|
(214
|
)
|
(10,482
|
)
|
|||||||||
Amortization
|
(24,098
|
)
|
(1,470
|
)
|
—
|
(1
|
)
|
(25,569
|
)
|
|||||||||
Operating
income
|
56,200
|
14,555
|
—
|
(8,645
|
)
|
62,110
|
(c)
|
|
||||||||||
Other
expense, net
|
(2,751
|
)
|
||||||||||||||||
Income from continuing operations before provision for
income taxes
|
$
|
59,359
|
||||||||||||||||
Depreciation
|
$
|
8,190
|
$
|
2,803
|
$
|
—
|
$
|
1,347
|
$
|
12,340
|
3.
|
Business
Segment Information
(continued)
|
Life
and
Laboratory
Sciences
|
Measurement
and Control
|
Eliminations
and Other
|
Corporate
|
Total
|
||||||||||||||
(In
thousands)
|
||||||||||||||||||
Nine
Months
Ended September 30, 2006
|
||||||||||||||||||
Revenues
|
$
|
1,595,111
|
$
|
527,606
|
$
|
—
|
$
|
—
|
$
|
2,122,717
|
||||||||
Adjusted
operating income (a)
|
$
|
279,237
|
$
|
74,899
|
$
|
(10,106
|
)
|
$
|
(34,478
|
)
|
$
|
309,552
|
(b)
|
|
||||
Cost
of revenues charges
|
(2,724
|
)
|
(526
|
)
|
—
|
—
|
(3,250
|
)
|
||||||||||
Restructuring
and other items
|
(6,586
|
)
|
(5,246
|
)
|
(9
|
)
|
(1,711
|
)
|
(13,552
|
)
|
||||||||
Stock
option compensation expense
|
(7,923
|
)
|
(2,183
|
)
|
10,106
|
—
|
—
|
|||||||||||
Amortization
|
(72,783
|
)
|
(4,838
|
)
|
—
|
—
|
(77,621
|
)
|
||||||||||
Operating
income
|
189,221
|
62,106
|
(9
|
)
|
(36,189
|
)
|
215,129
|
(b)
|
|
|||||||||
Other
expense, net
|
(12,905
|
)
|
||||||||||||||||
Income from continuing operations before
provision for income taxes
|
$
|
202,224
|
||||||||||||||||
Depreciation
|
$
|
27,039
|
$
|
6,647
|
$
|
—
|
$
|
4,955
|
$
|
38,641
|
||||||||
Nine
Months Ended October 1, 2005
|
||||||||||||||||||
Revenues
|
$
|
1,396,814
|
$
|
495,426
|
$
|
—
|
$
|
—
|
$
|
1,892,240
|
||||||||
Adjusted
operating income (a)
|
$
|
222,893
|
$
|
56,106
|
$
|
—
|
$
|
(26,259
|
)
|
$
|
252,740
|
(c)
|
|
|||||
Cost
of revenues charges
|
(12,374
|
)
|
(847
|
)
|
—
|
—
|
(13,221
|
)
|
||||||||||
Restructuring
and other items
|
(4,929
|
)
|
(6,647
|
)
|
573
|
(1,424
|
)
|
(12,427
|
)
|
|||||||||
Amortization
|
(48,485
|
)
|
(3,604
|
)
|
—
|
(3
|
)
|
(52,092
|
)
|
|||||||||
Operating
income
|
157,105
|
45,008
|
573
|
(27,686
|
)
|
175,000
|
(c)
|
|
||||||||||
Other
income, net
|
26,057
|
|||||||||||||||||
Income from continuing operations before
provision for income taxes
|
$
|
201,057
|
||||||||||||||||
Depreciation
|
$
|
22,733
|
$
|
7,264
|
$
|
—
|
$
|
3,255
|
$
|
33,252
|
(a)
|
Represents
operating income before restructuring and other costs, net; amortization
of acquisition-related intangible assets; and, for the business
segments,
stock option compensation expense.
|
(b)
|
Consolidated
adjusted operating income and consolidated operating income in
2006
include stock option compensation expense of $6.7 million in
the third
quarter ($0.8 million in cost of revenues, $5.5 million in selling,
general and administrative expenses and $0.4 million in research
and
development expenses) and $18.5 million in the first nine months
($2.1
million in cost of revenues, $15.3 million in selling, general
and
administrative expenses and $1.1 million in research and development
expenses. No stock option compensation expense has been capitalized
in
inventories due to immateriality.
|
(c)
|
Had
stock option expense been recorded in 2005, consolidated adjusted
operating income and consolidated operating income on a pro forma
basis
would have been lower by $5.2 million in the third quarter ($0.5
million
in cost of revenues, $4.4 million in selling, general and administrative
expenses and $0.3 million in research and development expenses)
and by
$15.7 million in the first nine months ($1.7 million in cost
of revenues,
$13.1 million in selling, general and administrative expenses
and $0.9
million in research and development
expenses).
|
4.
|
Other
Income (Expense), Net
|
Three
Months Ended
|
Nine
Months Ended
|
||||||||||||
September
30,
|
October
1,
|
September
30,
|
October
1,
|
||||||||||
(In
thousands)
|
2006
|
2005
|
2006
|
2005
|
|||||||||
Interest
Income
|
$
|
2,825
|
$
|
2,198
|
$
|
9,750
|
$
|
8,125
|
|||||
Interest
Expense
|
(9,278
|
)
|
(8,307
|
)
|
(25,007
|
)
|
(18,749
|
)
|
|||||
Gain
on Investments, Net
|
377
|
2,695
|
902
|
34,761
|
|||||||||
Other
Items, Net
|
333
|
663
|
1,450
|
1,920
|
|||||||||
$
|
(5,743
|
)
|
$
|
(2,751
|
)
|
$
|
(12,905
|
)
|
$
|
26,057
|
5.
|
Earnings
per Share
|
Three
Months Ended
|
Nine
Months Ended
|
||||||||||||
September
30,
|
October
1,
|
September
30,
|
October
1,
|
||||||||||
(In
thousands except per share amounts)
|
2006
|
2005
|
2006
|
2005
|
|||||||||
Income
from Continuing Operations
|
$
|
48,833
|
$
|
40,597
|
$
|
141,395
|
$
|
142,940
|
|||||
Gain on Disposal of Discontinued Operations
|
—
|
17,137
|
2,224
|
23,873
|
|||||||||
Net
Income for Basic Earnings per Share
|
48,833
|
57,734
|
143,619
|
166,813
|
|||||||||
Effect
of Convertible Debentures
|
402
|
402
|
1,205
|
1,205
|
|||||||||
Income
Available to Common Shareholders, as Adjusted for Diluted
Earnings per Share
|
$
|
49,235
|
$
|
58,136
|
$
|
144,824
|
$
|
168,018
|
|||||
Basic
Weighted Average Shares
|
157,705
|
161,794
|
160,680
|
161,335
|
|||||||||
Effect
of:
|
|||||||||||||
Stock
options
|
2,538
|
1,920
|
2,293
|
1,776
|
|||||||||
Convertible
debentures
|
1,846
|
1,846
|
1,846
|
1,846
|
|||||||||
Restricted stock awards and contingently issuable shares
|
72
|
75
|
70
|
51
|
|||||||||
Diluted
Weighted Average Shares
|
162,161
|
165,635
|
164,889
|
165,008
|
|||||||||
Basic
Earnings per Share:
|
|||||||||||||
Continuing
operations
|
$
|
.31
|
$
|
.25
|
$
|
.88
|
$
|
.89
|
|||||
Discontinued
operations
|
—
|
.11
|
.01
|
.15
|
|||||||||
$
|
.31
|
$
|
.36
|
$
|
.89
|
$
|
1.03
|
||||||
Diluted
Earnings per Share:
|
|||||||||||||
Continuing
operations
|
$
|
.30
|
$
|
.25
|
$
|
.86
|
$
|
.87
|
|||||
Discontinued
operations
|
—
|
.10
|
.01
|
.14
|
|||||||||
$
|
.30
|
$
|
.35
|
$
|
.88
|
$
|
1.02
|
6.
|
Comprehensive
Income and Shareholders’ Equity
|
7.
|
Stock-based
Compensation Plans and Stock-based Compensation
Expense
|
7.
|
Stock-based
Compensation Plans and Stock-based Compensation Expense
(continued)
|
Nine
Months Ended
|
|||||||
September
30,
|
October
1,
|
||||||
2006
|
2005
|
||||||
Expected
Stock Price Volatility
|
28%
|
|
32%
|
|
|||
Risk
Free Interest Rate
|
4.7%
|
|
3.8%
|
|
|||
Expected
Life of Options (years)
|
4.5
|
4.3
|
|||||
Expected
Annual Dividend per Share
|
$
|
—
|
$
|
—
|
7.
|
Stock-based
Compensation Plans and Stock-based Compensation Expense
(continued)
|
|
Shares
(In
thousands)
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Term
(In
years)
|
|
Aggregate
Intrinsic
Value
(a)
(In
thousands)
|
|
|||||||
Outstanding
at December 31, 2005
|
12,084
|
$
|
22.65
|
||||||||||
Granted
|
3,001
|
34.97
|
|||||||||||
Exercised
|
(1,377
|
)
|
19.15
|
||||||||||
Canceled
|
(199
|
)
|
29.02
|